Pharmaceutical - Asia-Pacific, Australia

Filter

Current filters:

Asia-PacificAustralia

Popular Filters

Pharmaceutical CPI growth due to Australian government policy

23-04-2014

The Australian Consumer Price Index (CPI) for the March quarter has shown growth in pharmaceutical prices…

Asia-PacificAustraliaPharmaceuticalPoliticsPricing

Australia to review program for life-saving drugs access

Australia to review program for life-saving drugs access

10-04-2014

The Australian government says that it will review the Life Saving Drugs Program (LSDP) - a move aimed…

Asia-PacificAustraliaFinancialHealthcarePharmaceuticalRare diseases

Price cuts mean PBS can afford new medicines, says Medicines Australia

Price cuts mean PBS can afford new medicines, says Medicines Australia

01-04-2014

As of today in Australia, price cuts come into effect for 121 medicines, and trade group Medicines Australia…

Asia-PacificAustraliaHealthcarePharmaceuticalPricing

PBS “a national treasure,” says Medicines Australia, but needs stable framework

PBS “a national treasure,” says Medicines Australia, but needs stable framework

20-03-2014

In his address to the country at the National Press Club in Canberra yesterday, Chairman of Medicines…

Asia-PacificAustraliaHealthcarePharmaceuticalPolitics

Latest Australian PBS Listings include medicines for children

Latest Australian PBS Listings include medicines for children

19-03-2014

Ten new medicines to treat a range of illnesses from rare forms of cancer to skin conditions will be…

Anti-Arthritics/RheumaticsAsia-PacificAustraliaDermatologicalsDiabetesGastro-intestinalsHealthcareOncologyPharmaceuticalPricing

Asia-Pacific NSCLC market to reach $2.9 billion by 2019

Asia-Pacific NSCLC market to reach $2.9 billion by 2019

18-03-2014

The non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region -…

Asia-PacificAustraliaChinaIndiaJapanMarkets & MarketingOncologyPharmaceutical

Streamlined PBS pricing processes to improve access to medicines in Australia

Streamlined PBS pricing processes to improve access to medicines in Australia

07-03-2014

From April 1, the Australian government will implement a new streamlined process to reduce the time taken…

Asia-PacificAustraliaPharmaceuticalPricingRegulation

Fresenius Kabi to invest A$47 million in Australian production plant

01-03-2014

Germany-based Fresenius Kabi is establishing a A$47 million ($42 million) state-of-the-art pharmaceutical…

Asia-PacificAustraliaFresenius KabiPharmaceuticalProduction

Australian patients benefit from PBS changes; cancer research

27-02-2014

New medicines for glaucoma, diabetes and advanced soft tissue sarcoma have been approved for listing…

Asia-PacificAustraliaDiabetesFinancialHealthcareKombiglyzeOncologyPharmaceuticalResearchTrajentaVotrient

Setting the record straight: Australia’s PBS expenditure is in decline

21-02-2014

Comments made this week by Australia’s federal Health Minister, Peter Dutton MP, about expenditure…

Asia-PacificAustraliaFinancialGenericsHealthcarePharmaceutical

New NPS MedicineWise annual evaluation report indicates Australian PBS savings

New NPS MedicineWise annual evaluation report indicates Australian PBS savings

18-02-2014

The 16th NPS MedicineWise Annual Evaluation Report provides a snapshot of the organization’s progress…

Asia-PacificAustraliaFinancialHealthcarePharmaceutical

ACCC acts on Pfizer’s alleged anti-competitive conduct in Australia

ACCC acts on Pfizer’s alleged anti-competitive conduct in Australia

13-02-2014

The Australian Competition and Consumer Commission revealed today that is has instituted proceedings…

Asia-PacificAustraliaCardio-vascularLegalLipitorMarkets & MarketingPfizerPharmaceutical

Australian industry calls on government to save the PBS

Australian industry calls on government to save the PBS

06-02-2014

Medicines Australia has called on the Australian government to save the Pharmaceutical Benefits Scheme…

Asia-PacificAustraliaHealthcarePatentsPharmaceuticalPolitics

Ariad Pharma plans commercialization of Iclusig in Australia

Ariad Pharma plans commercialization of Iclusig in Australia

28-01-2014

US specialty pharma firm Ariad Pharmaceuticals has signed an agreement with Specialised Therapeutics…

Ariad PharmaceuticalsAsia-PacificAustraliaIclusigLicensingOncologyPharmaceuticalSpecialised Therapeutics Australia

MRCF invests in Australian antibiotics start-up Auspherix

03-12-2013

Auspherix Pty, an early stage anti-infectives company developing novel antibiotics to treat resistant…

Antibiotics and Infectious diseasesAsia-PacificAuspherixAustraliaFinancialPharmaceuticalResearch

Medicines Australia calls on government to review PBS assessment process

Medicines Australia calls on government to review PBS assessment process

02-12-2013

Trade body Medicines Australia has submitted a report to the National Commission of Audit which shows…

Asia-PacificAustraliaHealthcarePharmaceuticalPoliticsPricing

Back to top